
Sign up to save your podcasts
Or
Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
4.4
6262 ratings
Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
17 Listeners
32 Listeners
14 Listeners
669 Listeners
11 Listeners
72 Listeners
0 Listeners
113 Listeners
43 Listeners
496 Listeners
58 Listeners
104 Listeners
43 Listeners
56 Listeners
8,721 Listeners
169 Listeners